Weekly CFO Buys Highlight: CHCR, VLY, ANCI, ROHI
COMPREHENSIVE CARE CORP (CHCR): CFO, 10% Owner Giuseppe Crisafi Bought 9,198 Shares
CFO, 10% Owner of COMPREHENSIVE CARE CORP (CHCR) Giuseppe Crisafi bought 9,198 shares on 12/15/2010 at an average price of $0.19. Comprehensive Care Corporation provides managed behavioral healthcare and substance abuse services for employers, HMOs, PPOs, government organizations, third-party claim administrators, and commercial and other group purchasers of behavioral healthcare services. with and P/S ratio of 0.73.
Comprehensive Care Corporation reported results for the third quarter ended September 30, 2010. Total revenue for the three months ended September 30, 2010 was $7.9 million compared to $3.6 million for the three months ended September 30, 2009. Net loss for the three months ended September 30, 2010 was ($3.7) million, or ($0.07) per basic and diluted share, compared to net loss of ($2.6) million, or ($0.06) per basic and diluted share for the three months ended September 30, 2009.
Chairman & CEO, 10% Owner Clark A. Marcus and CFO, 10% Owner Giuseppe Crisafi bought shares of CHCR stock.
Valley National Bancorp (VLY): Senior EVP & CFO Alan D Eskow Bought 8,500 Shares
Senior EVP & CFO of Valley National Bancorp (VLY) Alan D Eskow bought 8,500 shares on 12/15/2010 at an average price of $13.79. Valley National Bancorp is a bank holding company whose principal subsidiary is Valley National Bank. Valley National Bancorp has a market cap of $2.3 billion; its shares were traded at around $14.25 with a P/E ratio of 19.2 and P/S ratio of 2.9. The dividend yield of Valley National Bancorp stocks is 5%. Valley National Bancorp had an annual average earning growth of 0.1% over the past 10 years.
Valley National Bancorp reported net income for the third quarter of 2010 of $32.6 million, $0.20 per diluted common share, as compared to the third quarter of 2009 earnings of $25.6 million, after $6.0 million in dividends and accretion on Valley preferred stock, or $0.17 per diluted common share.
VLY is in the portfolios of Columbia Wanger of Columbia Wanger Asset Management, Jim Simons of Renaissance Technologies LLC, Louis Moore Bacon of Moore Capital Management, LP, Richard Snow of Snow Capital Management, L.P., Bruce Kovner of Caxton Associates, Jeremy Grantham of GMO LLC, Mario Gabelli of GAMCO Investors, Steven Cohen of SAC Capital Advisors, Chuck Royce of Royce& Associates.
Senior EVP & CFO Alan D Eskow and Director Barnett Rukin bought shares of VLY stock.
American Caresource Holdings Inc. (ANCI): CFO Matthew D. Thompson Bought 7,500 Shares
CFO of American Caresource Holdings Inc. (ANCI) Matthew D. Thompson bought 7,500 shares on 12/15/2010 at an average price of $1.44. American CareSource Holdings, Inc. a publicly traded ancillary care benefit management company, is a comprehensive ancillary care service provider offering a national network of more than twenty-ancillary providers. American Caresource Holdings Inc. has a market cap of $24.7 million; its shares were traded at around $1.46 with a P/E ratio of 18.4 and P/S ratio of 0.3.
American CareSource Holdings Inc. announced third quarter 2010 revenues of $14.8 million compared to $18.2 million reported during the third quarter of 2009. Net income for the period was $44,000, or$0.00 per diluted share, compared to $147,000, or $0.01 per diluted share, reported during the year ago period. Net income for the third quarter 2010 included a federal income tax provision of $43,000, which was not included in net income for the third quarter 2009.
ANCI is in the portfolios of Jim Simons of Renaissance Technologies LLC.
CFO Matthew D. Thompson and Director Kenneth S George bought shares of ANCI stock.
Rotech Healthcare Inc (ROHI): CFO Steven P Alsene Bought 5,851 Shares
CFO of Rotech Healthcare Inc (ROHI) Steven P Alsene bought 5,851 shares on 12/16/2010 at an average price of $1.89. Rotech Healthcare Inc. is a provider of home respiratory care and durable medical equipment and services to patients with breathing disorders such as chronic obstructive pulmonary diseases. with and P/S ratio of 0.1.
Rotech Healthcare Inc. announced financial results for the three and nine months ended September 30, 2010. The Company’s ratio of net debt to last twelve months Adjusted EBITDA decreased to 4.2 times compared to 4.6 times at June 30, 2010.
For the complete list of stocks that bought by their CFOs, go to: Insider Buys.